130 related articles for article (PubMed ID: 18236127)
21. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
[TBL] [Abstract][Full Text] [Related]
23. Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy.
Gebauer B; Werk M; Lopez-Hänninen E; Felix R; Althaus P
Cardiovasc Intervent Radiol; 2007; 30(4):644-9. PubMed ID: 17436034
[TBL] [Abstract][Full Text] [Related]
24. [Percutaneous CT-guided radiofrequency ablation for small renal masses : A retrospective, single center data analysis].
Heißler O; Seklehner S; Fellner H; Engelhardt PF; Chemelli A; Riedl C
Urologe A; 2018 Jul; 57(7):828-835. PubMed ID: 29797025
[TBL] [Abstract][Full Text] [Related]
25. Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up.
Lyrdal D; Andersson M; Hellström M; Sternal J; Lundstam S
Acta Radiol; 2010 Sep; 51(7):808-18. PubMed ID: 20707665
[TBL] [Abstract][Full Text] [Related]
26. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
[TBL] [Abstract][Full Text] [Related]
27. Radiofrequency ablation of renal tumors in the solitary kidney.
Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE
Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
[TBL] [Abstract][Full Text] [Related]
28. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors.
Dai Y; Covarrubias D; Uppot R; Arellano RS
J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657
[TBL] [Abstract][Full Text] [Related]
29. Microwave treatment of renal cell carcinoma adjacent to renal sinus.
Gao Y; Liang P; Yu X; Yu J; Cheng Z; Han Z; Duan S; Huang H
Eur J Radiol; 2016 Nov; 85(11):2083-2089. PubMed ID: 27776662
[TBL] [Abstract][Full Text] [Related]
30. Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience.
Clark TW; Malkowicz B; Stavropoulos SW; Sanchez R; Soulen MC; Itkin M; Patel A; Mondschein JI; Wein AJ
J Vasc Interv Radiol; 2006 Mar; 17(3):513-9. PubMed ID: 16567676
[TBL] [Abstract][Full Text] [Related]
31. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results.
Gupta A; Raman JD; Leveillee RJ; Wingo MS; Zeltser IS; Lotan Y; Trimmer C; Stern JM; Cadeddu JA
J Endourol; 2009 Jul; 23(7):1099-105. PubMed ID: 19530948
[TBL] [Abstract][Full Text] [Related]
32. Comparison of percutaneous radiofrequency ablation and open partial nephrectomy for the treatment of size- and location-matched renal masses.
Sung HH; Park BK; Kim CK; Choi HY; Lee HM
Int J Hyperthermia; 2012; 28(3):227-34. PubMed ID: 22515344
[TBL] [Abstract][Full Text] [Related]
33. Kidney neoplasms: renal halo sign after percutaneous radiofrequency ablation--incidence and clinical importance in 101 consecutive patients.
Schirmang TC; Mayo-Smith WW; Dupuy DE; Beland MD; Grand DJ
Radiology; 2009 Oct; 253(1):263-9. PubMed ID: 19703853
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous radiofrequency ablation of renal cell carcinoma: preliminary results.
Mahnken AH; Rohde D; Brkovic D; Günther RW; Tacke JA
Acta Radiol; 2005 Apr; 46(2):208-14. PubMed ID: 15902899
[TBL] [Abstract][Full Text] [Related]
36. Magnetic resonance-guided percutaneous radiofrequency ablation of renal cell carcinomas: a pilot clinical study.
Boss A; Clasen S; Kuczyk M; Anastasiadis A; Schmidt D; Graf H; Schick F; Claussen CD; Pereira PL
Invest Radiol; 2005 Sep; 40(9):583-90. PubMed ID: 16118551
[TBL] [Abstract][Full Text] [Related]
37. RFA of renal cell carcinoma in a solitary kidney.
Hoffmann RT; Jakobs TF; Trumm C; Helmberger TK; Reiser MF
Abdom Imaging; 2008; 33(2):230-6. PubMed ID: 17401600
[TBL] [Abstract][Full Text] [Related]
38. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
39. CT-guided bipolar and multipolar radiofrequency ablation (RF ablation) of renal cell carcinoma: specific technical aspects and clinical results.
Sommer CM; Lemm G; Hohenstein E; Bellemann N; Stampfl U; Goezen AS; Rassweiler J; Kauczor HU; Radeleff BA; Pereira PL
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):731-7. PubMed ID: 22926302
[TBL] [Abstract][Full Text] [Related]
40. Radiofrequency ablation of renal cell carcinoma in patients with a solitary kidney: a retrospective analysis of our experience.
Grasso RF; Luppi G; Faiella E; Giurazza F; Del Vescovo R; Cazzato RL; Beomonte Zobel B
Radiol Med; 2012 Jun; 117(4):606-15. PubMed ID: 22095427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
